Download PDF
Pneumologie 2004; 58(4): 230-237
DOI: 10.1055/s-2004-818411
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Gehauchte Diagnosen? Zum Potenzial von Atemkondensatuntersuchungen

Expired Diagnosis?-The Potential of Exhaled Breath AnalysisC.  Gessner1 , S.  Hammerschmidt1 , H.  Kuhn1 , H.  Wirtz1
  • 1Medizinische Klinik und Poliklinik I, Universitätsklinikum Leipzig (Direktor: Prof. Dr. med. J. Schauer)
Herrn Prof. Dr. med. Joachim Schauer zum 65. Geburtstag gewidmet.
Further Information

Publication History

Eingereicht: 5. Februar 2004

Nach Revision angenommen: 8. März 2004

Publication Date:
20 April 2004 (online)

Also available at
   Permissions and Reprints

Nicht-invasive Diagnostik in der Pneumologie

Zu den neueren Entwicklungen in der Pneumologie gehören nicht-invasive Methoden der Informationsgewinnung aus den Atemwegen und dem Lungenparenchym. Zu diesen Methoden zählen das induzierte Sputum und das Atemkondensat sowie die Online-Messung von flüchtigen Substanzen in der Expirationsluft [1]. Diese Methoden stellen den Beginn einer Entwicklung dar, deren Ziel es ist, auf einfache Weise weitergehende Informationen über die Lunge zu erhalten und damit invasivere Diagnostik sparsam, ökonomisch und zielgerichtet einzusetzen. Gleichzeitig soll damit aber auch eine Screeningdiagnostik ermöglicht werden, die auf einen wesentlich größeren Kreis von potenziell Erkrankten ausgedehnt werden kann, als dies bisher für Erkrankungen der Lunge möglich war, von der rein funktionellen Möglichkeit der Atemflussanalyse einmal abgesehen.

Technisch einfacher noch als die Gewinnung von Sputum nach vorheriger Inhalation von 3 %iger Kochsalzlösung ist die Messung von Substanzen, die entweder gasförmig oder eingeschlossen in aerosolisierte Tröpfchen in der Ausatemluft enthalten sind. Dabei entstehen keinerlei Auswirkungen auf das Bronchialsystem, zumal diese Messungen am ruhig atmenden Patienten stattfinden können.

Zu den Mediatoren, die online (also ohne vorherige Sammlung und spätere Messung) bestimmbar sind, gehören Stickstoffmonoxid (NO) und Kohlenmonoxid (CO). Gegenwärtig gibt es vor allem Daten zum Stickstoffmonoxid [2] [3]. In verschiedenen Untersuchungen wurde ein Zusammenhang zwischen der NO-Konzentration in der Ausatemluft und dem Asthma bronchiale gefunden [4] [5] [6] [7] [8]. Mehrere Arbeiten haben sich mit der Standardisierung der Methode befasst [9] und festgelegt, dass die Ausatmung bei der Online-NO-Messung gegen einen fixen Widerstand stattfinden muss, wodurch sich das Gaumensegel verschließt und eine Kontamination des aus der Lunge stammenden Gases durch Nasenluft mit hoher Stickstoffmonoxid-Konzentration vermieden wird.

Das Exhalat enthält neben gasförmigen Bestandteilen auch eine Aerosolfraktion und vor allem Wasserdampf. Anteile dieser letzten beiden Bestandteile der Ausatemluft stellen den Hauptanteil des so genannten Atemkondensates (AK entspricht exhaled breath condensate: EBC) dar. In der Aerosolfraktion sind auch größere Moleküle wie Protein und DNA enthalten. Diesem Umstand verdankt das Atemkondensat seine potenzielle Bedeutung als Methode für Screening und Diagnostik von Lungenkrankheiten. Nachfolgende Übersicht soll darstellen, welche Möglichkeiten und Grenzen der Methode derzeit gegeben sind.

Literatur

  • 1 Kharitonov S A, Barnes P J. Exhaled markers of pulmonary disease.  Am J Respir Crit Care Med. 2001;  163 (7) 1693-1722
    PubMedGoogle Scholar
  • 2 Ricciardolo F L. Multiple roles of nitric oxide in the airways.  Thorax. 2003;  58 (2) 175-182
    CrossrefPubMedGoogle Scholar
  • 3 Paredi P, Kharitonov S A, Barnes P J. Analysis of expired air for oxidation products.  Am J Respir Crit Care Med. 2002;  166 (12 Pt 2) S31-37
    CrossrefPubMedGoogle Scholar
  • 4 Silkoff P E, Martin D, Pak J. et al . Exhaled nitric oxide correlated with induced sputum findings in COPD.  Chest. 2001;  119 (4) 1049-1055
    CrossrefPubMedGoogle Scholar
  • 5 Blease K, Kunkel S L, Hogaboam C M. Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness, eosinophilia and C-C chemokine generation in a murine model of fungal asthma.  Inflamm Res. 2000;  49 (6) 297-304
    PubMedGoogle Scholar
  • 6 Feder L S, Stelts D, Chapman R W. et al . Role of nitric oxide on eosinophilic lung inflammation in allergic mice.  Am J Respir Cell Mol Biol. 1997;  17 (4) 436-442
    PubMedGoogle Scholar
  • 7 Strunk R C, Szefler S J, Phillips B R. et al . Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.  J Allergy Clin Immunol. 2003;  112 (5) 883-892
    CrossrefPubMedGoogle Scholar
  • 8 Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients.  J Asthma. 2003;  40 (6) 653-659
    CrossrefPubMedGoogle Scholar
  • 9 Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.  Am J Respir Crit Care Med. 1999;  160 (6) 2104-2117
    PubMedGoogle Scholar
  • 10 Fairchild C I, Stampfer J F. Particle concentration in exhaled breath.  Am Ind Hyg Assoc J. 1987;  48 (11) 948-949
    CrossrefPubMedGoogle Scholar
  • 11 Jorres R A, Holz O. [Non-invasive inflammation monitoring].  Pneumologie. 2001;  55 (9) 406-408
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Becher G, Beck E, Rothe M. et al . Sammlung von nichtgasförmigen Bestandteilen des Ausatemluft durch Ausfrieren.  Medizintechnik. 1997;  117 89-95
    PubMedGoogle Scholar
  • 13 Griese M, Noss J, Bredow C von. Protein pattern of exhaled breath condensate and saliva.  Proteomics. 2002;  2 (6) 690-696
    CrossrefPubMedGoogle Scholar
  • 14 Effros R M, Hoagland K W, Bosbous M. et al . Dilution of respiratory solutes in exhaled condensates.  Am J Respir Crit Care Med. 2002;  165 (5) 663-669
    PubMedGoogle Scholar
  • 15 Gessner C, Kuhn H, Seyfarth H J. et al . Factors influencing breath condensate volume.  Pneumologie. 2001;  55 (9) 414-419
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Vass G, Huszar E, Barat E. et al . Comparison of nasal and oral inhalation during exhaled breath condensate collection.  Am J Respir Crit Care Med. 2003;  167 (6) 850-855
    CrossrefPubMedGoogle Scholar
  • 17 Huszar E, Vass G, Vizi E. et al . Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma.  Eur Respir J. 2002;  20 (6) 1393-1398
    CrossrefPubMedGoogle Scholar
  • 18 Begin R, Drapeau G, Boileau R. et al . Enzyme activities of lung lavage in asbestosis.  Clin Biochem. 1986;  19 (4) 240-243
    PubMedGoogle Scholar
  • 19 Rao S. Amylase in bronchial washings as an aid to early diagnosis of bronchogenic carcinoma.  J Assoc Physicians India. 1995;  43 (6) 400
    PubMedGoogle Scholar
  • 20 Kietzmann D, Kahl R, Muller M. et al . Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.  Intensive Care Med. 1993;  19 (2) 78-81
    CrossrefPubMedGoogle Scholar
  • 21 Corradi M, Rubinstein I, Andreoli R. et al . Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2003;  167 (10) 1380-1386
    CrossrefPubMedGoogle Scholar
  • 22 Corradi M, Folesani G, Andreoli R. et al . Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation.  Am J Respir Crit Care Med. 2003;  167 (3) 395-399
    CrossrefPubMedGoogle Scholar
  • 23 Montuschi P, Ragazzoni E, Valente S. et al . Ciabattoni. Validation of leukotriene B4 measurements in exhaled breath condensate.  Inflamm Res. 2003;  52 (2) 69-73
    CrossrefPubMedGoogle Scholar
  • 24 Gessner C, Hammerschmidt S, Kuhn H. et al . Exhaled breath condensate acidification in acute lung injury.  Respir Med. 2003;  97 (11) 1188-1194
    CrossrefPubMedGoogle Scholar
  • 25 Montuschi P, Ragazzoni E, Valente S. et al . Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate.  Inflamm Res. 2003;  52 (12) 502-507
    CrossrefPubMedGoogle Scholar
  • 26 Bucchioni E, Kharitonov S A, Allegra L. et al . High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.  Respir Med. 2003;  97 (12) 1299-1302
    PubMedGoogle Scholar
  • 27 Carpagnano G E, Resta O, Foschino-Barbaro M P. et al . Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer.  Int J Biol Markers. 2002;  17 (2) 141-145
    PubMedGoogle Scholar
  • 28 Carpagnano G E, Barnes P J, Geddes D M. et al . Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.  Am J Respir Crit Care Med. 2003;  167 (8) 1109-1112
    CrossrefPubMedGoogle Scholar
  • 29 Carpagnano G E, Kharitonov S A, Foschino-Barbaro M P. et al . Increased inflammatory markers in the exhaled breath condensate of cigarette smokers.  Eur Respir J. 2003;  21 (4) 589-593
    PubMedGoogle Scholar
  • 30 Shahid S K, Kharitonov S A, Wilson N M. et al . Increased interleukin-4 and decreased interferon-γ in exhaled breath condensate of children with asthma.  Am J Respir Crit Care Med. 2002;  165 (9) 1290-1293
    CrossrefPubMedGoogle Scholar
  • 31 Scheideler L, Manke H G, Schwulera U. et al . Detection of nonvolatile macromolecules in breath. A possible diagnostic tool?.  Am Rev Respir Dis. 1993;  148 (3) 778-784
    PubMedGoogle Scholar
  • 32 Effros R M, Biller J, Foss B. et al . A simple method for estimating respiratory solute dilution in exhaled breath condensates.  Am J Respir Crit Care Med. 2003;  168 (12) 1500-1505
    CrossrefPubMedGoogle Scholar
  • 33 Gessner C, Hammerschmidt S, Kuhn H. et al . Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury.  Chest. 2003;  124 (3) 1046-1052
    CrossrefPubMedGoogle Scholar
  • 34 Conner G E, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway.  Am J Respir Crit Care Med. 2002;  166 (12 Pt 2) S57-61
    CrossrefPubMedGoogle Scholar
  • 35 Horvath I, MacNee W, Kelly F J. et al . “Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases”, summary of the ERS Research Seminar in Budapest, Hungary, September, 1999.  Eur Respir J. 2001;  18 (2) 420-430
    CrossrefPubMedGoogle Scholar
  • 36 Schleiss M B, Holz O, Behnke M. et al . The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate.  Eur Respir J. 2000;  16 (6) 1115-1118
    CrossrefPubMedGoogle Scholar
  • 37 Beurden W J van, Dekhuijzen P N, Harff G A. et al . Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls.  Respiration. 2002;  69 (3) 211-216
    CrossrefPubMedGoogle Scholar
  • 38 Lehmann C, Rothe M, Becher B. A new method for rapid measurement of hydrogen peroxide in exhaled breath condensate.  Am J Respir Crit Care Med. 2002;  165 53 (Abstract)
    PubMedGoogle Scholar
  • 39 Dohlman A W, Black H R, Royall J A. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma.  Am Rev Respir Dis. 1993;  148 (4 Pt 1) 955-960
    PubMedGoogle Scholar
  • 40 Antczak A, Nowak D, Shariati B. et al . Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients.  Eur Respir J. 1997;  10 (6) 1235-1241
    CrossrefPubMedGoogle Scholar
  • 41 Antczak A, Kurmanowska Z, Kasielski M. et al . Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients.  Respir Med. 2000;  94 (5) 416-421
    PubMedGoogle Scholar
  • 42 Horvath I, Donnelly L E, Kiss A. et al . Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma.  Am J Respir Crit Care Med. 1998;  158 (4) 1042-1046
    PubMedGoogle Scholar
  • 43 Nowak D, Antczak A, Krol M. et al . Increased content of hydrogen peroxide in the expired breath of cigarette smokers.  Eur Respir J. 1996;  9 (4) 652-657
    CrossrefPubMedGoogle Scholar
  • 44 Dekhuijzen P N, Aben K K, Dekker I. et al . Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1996;  154 (3 Pt 1) 813-816
    CrossrefPubMedGoogle Scholar
  • 45 Nowak D, Kasielski M, Pietras T. et al . Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD.  Monaldi Arch Chest Dis. 1998;  53 (3) 268-273
    PubMedGoogle Scholar
  • 46 Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.  Respir Med. 2001;  95 (6) 448-456
    CrossrefPubMedGoogle Scholar
  • 47 De Benedetto F, Aceto A, Dragani B. et al . Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients.  Monaldi Arch Chest Dis. 2000;  55 (3) 185-188
    PubMedGoogle Scholar
  • 48 Loukides S, Horvath I, Wodehouse T. et al . Elevated levels of expired breath hydrogen peroxide in bronchiectasis.  Am J Respir Crit Care Med. 1998;  158 (3) 991-994
    PubMedGoogle Scholar
  • 49 Loukides S, Bouros D, Papatheodorou G. et al . Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease.  Chest. 2002;  121 (1) 81-87
    CrossrefPubMedGoogle Scholar
  • 50 Worlitzsch D, Herberth G, Ulrich M. et al . Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis.  Eur Respir J. 1998;  11 (2) 377-383
    CrossrefPubMedGoogle Scholar
  • 51 Jobsis Q, Raatgeep H C, Schellekens S L. et al . Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment.  Eur Respir J. 2000;  16 (1) 95-100
    CrossrefPubMedGoogle Scholar
  • 52 Baldwin S R, Simon R H, Grum C M. et al . Oxidant activity in expired breath of patients with adult respiratory distress syndrome.  Lancet. 1986;  1 (8471) 11-14
    PubMedGoogle Scholar
  • 53 Heard S O, Longtine K, Toth I. et al . The influence of liposome-encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome.  Anesth Analg. 1999;  89 (2) 353-357
    PubMedGoogle Scholar
  • 54 Nowak D, Kasielski M, Antczak A. et al . Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.  Respir Med. 1999;  93 (6) 389-396
    CrossrefPubMedGoogle Scholar
  • 55 Ferreira I M, Hazari M S, Gutierrez C. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone.  Am J Respir Crit Care Med. 2001;  164 (6) 1012-1015
    PubMedGoogle Scholar
  • 56 Beurden W J van, Harff G A, Dekhuijzen P N. et al . An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate.  Respir Med. 2002;  96 (3) 197-203
    PubMedGoogle Scholar
  • 57 Zappacosta B, Persichilli S, Mormile F. et al . A fast chemiluminescent method for H(2)O(2) measurement in exhaled breath condensate.  Clin Chim Acta. 2001;  310 (2) 187-191
    CrossrefPubMedGoogle Scholar
  • 58 Ho L P, Innes J A, Greening A P. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.  Thorax. 1998;  53 (8) 680-684
    CrossrefPubMedGoogle Scholar
  • 59 Kostikas K, Papatheodorou G, Ganas K. et al . pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases.  Am J Respir Crit Care Med. 2002;  165 (10) 1364-1370
    CrossrefPubMedGoogle Scholar
  • 60 Corradi M, Pesci A, Casana R. et al . Nitrate in exhaled breath condensate of patients with different airway diseases.  Nitric Oxide. 2003;  8 (1) 26-30
    CrossrefPubMedGoogle Scholar
  • 61 Cunningham S, McColm J R, Ho L P. et al . Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis.  Eur Respir J. 2000;  15 (5) 955-957
    CrossrefPubMedGoogle Scholar
  • 62 Formanek W, Inci D, Lauener R P. et al . Elevated nitrite in breath condensates of children with respiratory disease.  Eur Respir J. 2002;  19 (3) 487-491
    CrossrefPubMedGoogle Scholar
  • 63 Kharitonov S A, Donnelly L E, Montuschi P. et al . Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.  Thorax. 2002;  57 (10) 889-896
    CrossrefPubMedGoogle Scholar
  • 64 Hunt J, Byrns R E, Ignarro L J. et al . Condensed expirate nitrite as a home marker for acute asthma [letter].  Lancet. 1995;  346 (8984) 1235-1236
    PubMedGoogle Scholar
  • 65 Ganas K, Loukides S, Papatheodorou G. et al . Total nitrite/nitrate in expired breath condensate of patients with asthma.  Respir Med. 2001;  95 (8) 649-654
    PubMedGoogle Scholar
  • 66 Hanazawa T, Kharitonov S A, Barnes P J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma.  Am J Respir Crit Care Med. 2000;  162 (4 Pt 1) 1273-1276
    PubMedGoogle Scholar
  • 67 Balint B, Kharitonov S A, Hanazawa T. et al . Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis.  Eur Respir J. 2001;  17 (6) 1201-1207
    CrossrefPubMedGoogle Scholar
  • 68 Rothe M, Becher G, Kragl U. et al . Bestimmung von Tyrosin und Nitrotyrosin im Atemkondensat von CF-Patienten.  Pneumologie. 2003;  57 S52 (Abstract)
    PubMedGoogle Scholar
  • 69 Corradi M, Montuschi P, Donnelly L E. et al . Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.  Am J Respir Crit Care Med. 2001;  163 (4) 854-858
    PubMedGoogle Scholar
  • 70 Driver A G, Kukoly C A, Ali S. et al . Adenosine in bronchoalveolar lavage fluid in asthma.  Am Rev Respir Dis. 1993;  148 (1) 91-97
    PubMedGoogle Scholar
  • 71 Mann J S, Holgate S T, Renwick A G. et al . Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma.  J Appl Physiol. 1986;  61 (5) 1667-1676
    PubMedGoogle Scholar
  • 72 Vizi E, Huszar E, Csoma Z. et al . Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma.  J Allergy Clin Immunol. 2002;  109 (3) 446-448
    CrossrefPubMedGoogle Scholar
  • 73 Antczak A, Montuschi P, Kharitonov S. et al . Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma.  Am J Respir Crit Care Med. 2002;  166 (3) 301-306
    CrossrefPubMedGoogle Scholar
  • 74 Montuschi P, Kharitonov S A, Ciabattoni G. et al . Exhaled leukotrienes and prostaglandins in COPD.  Thorax. 2003;  58 (7) 585-588
    CrossrefPubMedGoogle Scholar
  • 75 Reinhold P, Becher G, Rothe M. Evaluation of the measurement of leukotriene B4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves.  Am J Vet Res. 2000;  61 (7) 742-749
    PubMedGoogle Scholar
  • 76 Csoma Z, Kharitonov S A, Balint B. et al . Increased leukotrienes in exhaled breath condensate in childhood asthma.  Am J Respir Crit Care Med. 2002;  166 (10) 1345-1349
    CrossrefPubMedGoogle Scholar
  • 77 Neubauer B, Struck N, Mutzbauer T S. et al . Leukotriene-B4 concentrations in exhaled breath condensate and lung function after thirty minutes of breathing technically dried compressed air.  Int Marit Health. 2002;  53 (1 - 4) 93-101
    PubMedGoogle Scholar
  • 78 Montuschi P, Barnes P J. Exhaled leukotrienes and prostaglandins in asthma.  J Allergy Clin Immunol. 2002;  109 (4) 615-620
    CrossrefPubMedGoogle Scholar
  • 79 Becher G, Winsel K, Beck E. et al . Leukotriene B4 in breathing condensate of patients with bronchopulmonary diseases and of normal patients.  Appl Cardiopulmon Pathophysiol. 1995;  5 215-219
    PubMedGoogle Scholar
  • 80 Baraldi E, Carraio S, Alinovi R. et al . Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.  Thorax. 2003;  58 (6) 505-509
    CrossrefPubMedGoogle Scholar
  • 81 Cap P, Pehal F, Petru V. et al . Leukotrienes in breath condensate in patients with asthma and COPD.  Alergie. 2002;  1 15-20
    PubMedGoogle Scholar
  • 82 Janssen L J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology.  Am J Physiol Lung Cell Mol Physiol. 2001;  280 (6) L1067-1082
    PubMedGoogle Scholar
  • 83 Baraldi E, Ghiro L, Piovan V. et al . Increased exhaled 8-isoprostane in childhood asthma.  Chest. 2003;  124 (1) 25-31
    CrossrefPubMedGoogle Scholar
  • 84 Montuschi P, Collins J V, Ciabattoni G. et al . Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.  Am J Respir Crit Care Med. 2000;  162 (3 Pt 1) 1175-1177
    CrossrefPubMedGoogle Scholar
  • 85 Montuschi P, Ciabattoni G, Paredi P. et al . 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.  Am J Respir Crit Care Med. 1998;  158 (5 Pt 1) 1524-1527
    PubMedGoogle Scholar
  • 86 Montuschi P, Kharitonov S A, Ciabattoni G. et al . Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.  Thorax. 2000;  55 (3) 205-209 [Record as supplied by publisher]
    CrossrefPubMedGoogle Scholar
  • 87 Carpenter C T, Price P V, Christman B W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS.  Chest. 1998;  114 (6) 1653-1659
    PubMedGoogle Scholar
  • 88 Carpagnano G E, Kharitonov S A, Resta O. et al . Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients.  Chest. 2002;  122 (4) 1162-1167
    CrossrefPubMedGoogle Scholar
  • 89 Nowak D, Kalucka S, Bialasiewicz P. et al . Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects.  Free Radic Biol Med. 2001;  30 (2) 178-186
    CrossrefPubMedGoogle Scholar
  • 90 Larstad M, Ljungkvist G, Olin A C. et al . Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection.  J Chromatogr B Analyt Technol Biomed Life Sci. 2002;  766 (1) 107-114
    PubMedGoogle Scholar
  • 91 Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology.  Toxicology. 2000;  153 (1 - 3) 83-104
    CrossrefPubMedGoogle Scholar
  • 92 Hunt J F, Fang K, Malik R. et al . Endogenous airway acidification. Implications for asthma pathophysiology [see comments].  Am J Respir Crit Care Med. 2000;  161 (3 Pt 1) 694-699
    PubMedGoogle Scholar
  • 93 Tate S, MacGregor G, Davis M. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate.  Thorax. 2002;  57 (11) 926-929
    CrossrefPubMedGoogle Scholar
  • 94 Vaughan J, Ngamtrakulpanit L, Pajewski T. et al . Exhaled breath condensate pH is a robust and reproducible assay of airway chemistry.  Eur Respir J. 2003;  in press
    PubMedGoogle Scholar
  • 95 Hunt J F, Erwin E, Palmer L. et al . Expression and activity of pH-regulatory glutaminase in the human airway epithelium.  Am J Respir Crit Care Med. 2002;  165 (1) 101-107
    PubMedGoogle Scholar
  • 96 Ho L P, Faccenda J, Innes J A. et al . Expired hydrogen peroxide in breath condensate of cystic fibrosis patients.  Eur Respir J. 1999;  13 (1) 103-106
    CrossrefPubMedGoogle Scholar
  • 97 McRae K, De Perrot M, Fischer S. et al . Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation.  J Heart Lung Transplant. 2001;  20 (2) 184
    PubMedGoogle Scholar
  • 98 Carpagnano G E, Kharitonov S A, Wells A U. et al . Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease.  Respiration. 2003;  70 (2) 154-160
    CrossrefPubMedGoogle Scholar
  • 99 Nayeri F, Millinger E, Nilsson I. et al . Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia.  Respir Med. 2002;  96 (2) 115-119
    PubMedGoogle Scholar

Dr. Christian Gessner

Medizinische Klinik und Poliklinik I · Universitätsklinikum Leipzig

Johannisallee 32

04103 Leipzig

Email: gesc@medizin.uni-leipzig.de